


Healthcare Industry News: HIV/AIDS
News Release - October 16, 2006
Human Genome Sciences Reports Positive Interim Quality-of-Life Data From Phase 2B Trial of Albuferon(TM) with Ribavirin in Treatment-Naive Hepatitis C Patients
Source: Human Genome Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
